Wegovy

Indicated For

Chronic weight management, obesity, overweight with weight-related conditions

About This Medication

# Novo Nordisk Patient Assistance Program (PAP) Patient Guide: How to Get Wegovy (semaglutide) at Low or No Cost **Important Note:** The Novo Nordisk Patient Assistance Program (PAP) does not currently cover Wegovy (semaglutide). This guide explains why, who might qualify for general PAP support with other medications, and details **alternative low-cost options** from Novo Nordisk to access Wegovy affordably. These include savings cards and self-pay offers that can reduce costs to as low as $0-$349 per month for eligible patients.[1][2][3][5] ## About Wegovy (semaglutide) Wegovy is an FDA-approved injectable (and now tablet) medication containing **semaglutide**, a GLP-1 receptor agonist. It helps reduce excess body weight and maintain weight loss long-term when combined with a reduced-calorie diet and increased physical activity. It's indicated for: - Adults and children 12+ with obesity. - Adults who are overweight with at least one weight-related condition (e.g., type 2 diabetes, high blood pressure, high cholesterol). - Reducing major cardiovascular risks (e.g., heart attack, stroke) in adults with established heart disease, obesity, or overweight.[3] **How it works:** Semaglutide mimics a hormone that regulates appetite, slows digestion, and signals fullness, leading to reduced calorie intake and weight loss. Typical use is weekly injections starting at low doses (0.25 mg) titrating up to 2.4 mg. Results show 15-20% body weight reduction in clinical trials, but success requires lifestyle changes.[2][3] Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain. Serious risks: thyroid tumors (boxed warning), pancreatitis, gallbladder issues, low blood sugar (if diabetic). Always consult your doctor.[2] Wegovy lists around $1,300-$1,700 monthly without assistance, making affordability a key barrier.[3][5] ## Who Qualifies for Assistance? **Novo Nordisk PAP does not cover Wegovy.** It's for low-income, uninsured, or underinsured patients on other Novo Nordisk drugs (e.g., Ozempic or Rybelsus for diabetes, which also contain semaglutide).[2][4][9] General PAP eligibility typically includes: - U.S. residents (excluding certain territories). - Household income at or below 400-500% of the Federal Poverty Level (FPL). - No government insurance or private coverage for the medication. - U.S. prescribing doctor.[1][4][8] Since Wegovy is excluded, focus on **Novo Nordisk savings programs**:[3][5][6] - **Commercial insurance:** Savings card pays as little as **$25/month** (max $100 savings/month). Excludes government insurance.[3] - **Self-pay/uninsured:** **$149/month** for 1.5 mg and 4 mg doses (4 mg until Aug 31, 2026, then $199); **$199/month** for starter doses (0.25/0.5 mg, new patients); **$349/month** all doses via NovoCare Pharmacy.[3][5][6] - Additional perks: 1-on-1 coaching, progress tracking, reminders via WeGoTogether.[2] ## Income Eligibility Breakdown No income test for Wegovy savings cards—eligibility is insurance-based. For general PAP (non-Wegovy drugs), thresholds are ~400% FPL. Example 2026 FPL table for household of 1-4 (adjust annually; check NovoCare.com): | Household Size | 400% FPL Annual Income | 500% FPL Annual Income | |----------------|-------------------------|-------------------------| | 1 | $60,240 | $75,300 | | 2 | $81,760 | $102,200 | | 3 | $103,280 | $129,100 | | 4 | $124,800 | $156,000 | *Add ~$21,520 per person for larger households at 400% FPL. Proof: tax returns, pay stubs.[1][4] ## Insurance Requirements - **PAP:** Wegovy **not covered**. Must be uninsured/underinsured for eligible drugs.[1][2] - **Savings Card:** Commercial/private insurance only. **Medicare/Medicaid excluded** (government beneficiaries ineligible).[3] - Check coverage at WegovyCoverage.com (90 seconds).[3] If denied, use self-pay options via NovoCare Pharmacy (CenterWell or CoAssist).[3] ## Step-by-Step Application for Wegovy Savings 1. **Verify eligibility:** Visit NovoCare.com or Wegovy.com. Use coverage checker.[3][5] 2. **Get prescription:** From your doctor (U.S.-licensed).[1] 3. **Activate savings card:** Download at NovoCare.com/wegovy/savings-offer or text/app. Activate online or pharmacy.[3][6] 4. **Fill at pharmacy:** Present card + Rx. For self-pay, use NovoCare Pharmacy.[3] 5. **Enroll in support:** Optional WeGoTogether for coaching/tools.[2] No formal PAP app for Wegovy—savings are instant for eligible.[1][2] ## Timeline and Delivery - **Savings approval:** Immediate at pharmacy with card.[3] - **Self-pay via NovoCare:** Ships directly (details post-Rx submission).[3] - **General PAP (other drugs):** 2-4 weeks processing; annual re-enrollment. Meds shipped free.[1][4] - Refills: Monthly; track via app.[2] ## Alternatives if Denied or Ineligible - **PAN Foundation:** Up to $1,000 grant for obesity treatments including GLP-1s like Wegovy. Income <500% FPL, U.S. resident.[7] - **Ozempic/Rybelsus PAP:** Same semaglutide for diabetes (if eligible).[2][4] - **Compounded semaglutide:** Cheaper but **risky**—not FDA-approved, absorption issues.[3] - **GoodRx/coupons:** ~$1,200/month discounts. - Doctor/pharmacist for generics or trials.[1][2] ## Disclaimer This guide is for informational purposes only and not medical/financial advice. Program details change (e.g., offers expire Aug 2026).[3] Eligibility varies; confirm at NovoCare.com or 1-888-693-6742. Consult your healthcare provider before starting Wegovy. Novo Nordisk reserves rights to modify/cancel.[1][2][3] Word count: 942.

Program information last verified: March 25, 2026